Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Cancer Biomarker Research and Personalized Medicine
| Cancer Biomarker Research and Personalized Medicine |
| Autore | Meehan James |
| Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 online resource (428 p.) |
| Soggetto topico |
Medicine and Nursing
Oncology |
| Soggetto non controllato |
1H-NMR
Akt/mTOR AmpliSeq anastomotic leak autophagy bioinformatics biomarker biomarkers bladder tumor breast cancer cancer biomarkers cancer vaccine chemoradiotherapy chemoresistance chemotherapy circulating tumor cells clear cell renal cell carcinoma colorectal cancer comparative oncology CREB1 cytokine signalling DNA methylation drug perturbation epigenetics exosomes FOXO3 gastric cancer GBP5 glycopeptide gp130 haptoglobin head and neck cancer head and neck squamous cell carcinoma hepatocellular carcinoma HNSCC hormone-dependent carcinogenesis HPV genotyping IL13Rα2 IL6ST immune response intestinal anastomosis JAK2 LC-MS/MS lincRNA-p21 lipidomics lipoprotein lipase lipoprotein subfractions liquid biopsy liquid-based biomarkers localized prostate cancer long non-coding RNA lymph node metastasis lymphocyte-to-monocyte ratio mass spectrometry meta-analysis microRNA middle-up-down multiphasic multidetector computed tomography n/a One Health ovarian cancer p16 expression p53 peripheral blood parameters personalized medicine precision medicine predictive biomarker predictive tools prognostic factors prognostic tools prostate cancer radiomics radioresistance radiosensitivity biomarkers radiotherapy rectal cancer renal cell carcinoma saliva secretome taxane telmisartan tissue-based biomarkers translational research transurethral resection triple-negative breast cancer tumor recurrence WHO/ISUP nuclear grade |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910674370003321 |
Meehan James
|
||
| Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Colorectal Cancers: From Present Problems to Future Solutions
| Colorectal Cancers: From Present Problems to Future Solutions |
| Autore | Allgayer Heike |
| Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 online resource (238 p.) |
| Soggetto topico |
Medicine and Nursing
Oncology |
| Soggetto non controllato |
(molecular) carcinogenesis
(single) cancer cell heterogeneity (targeted) therapy bacteriophages biomarker blood values bovine meat and milk factors (BMMF) cancer cancer progression CellSearch® system chromatin density chronic zoonosis circulating tumor cells cohort colon cancer colorectal colorectal cancer comparative oncology CTNNB1 deposited energy diet DKK1 DNA double-strand breaks drug combinations early onset epidemiology EPISPOT assay gender genome-wide methylation array immune landscape indirect carcinogenesis infection infectious agents liquid biopsy Matrix Metalloproteinases (MMPs) metastasis methylation microRNAs miRNA MMP polymorphisms MMP targeting models multiplex nanoscale nutrition patient survival personalized medicine personalized treatment Phage polyp predictive value quality of life radiochemotherapy radiosensitivity rectal cancer S100A4 spontaneous feline intestinal tumors super-resolution microscopy TIMPs tumor budding tumor immunology tumour cell heterogeneity Wnt signaling |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Colorectal Cancers |
| Record Nr. | UNINA-9910585937103321 |
|
Allgayer Heike
|
||
| Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Emerging Translational Opportunities in Comparative Oncology with Companion Canine Cancers
| Emerging Translational Opportunities in Comparative Oncology with Companion Canine Cancers |
| Autore | Dewhirst Mark W |
| Pubbl/distr/stampa | Frontiers Media SA, 2020 |
| Descrizione fisica | 1 online resource (201 p.) |
| Soggetto topico |
Medicine and Nursing
Oncology |
| Soggetto non controllato |
cancer biology
cancer diagnostic cancer therapy canine comparative oncology |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557434303321 |
|
Dewhirst Mark W
|
||
| Frontiers Media SA, 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Targeting STAT3 and STAT5 in Cancer
| Targeting STAT3 and STAT5 in Cancer |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
| Descrizione fisica | 1 online resource (578 p.) |
| Soggetto topico |
Biology, life sciences
Research & information: general |
| Soggetto non controllato |
ADAM17
adoptive T cell therapy AKT androgens apoptosis autoimmune disease autosomal-dominant hyper IgE syndrome Bone Marrow Failure Syndromes breast cancer cancer cancer models cancer progression cancer-stem cell CD38 CD4+ T cells CD8+ T cells cell cycle cell hierarchy chaperones chemotherapy resistance cirrhosis colon cancer companion animals comparative oncology cytokine cytokine receptor signaling dynamic programming endoplasmic reticulum (ER) stress epidermal growth factor receptor (EGF-R) ERK1/2 escape mechanisms gain-of-function mutation glioblastoma glioma growth hormone insensitivity syndrome heat shock proteins hedging hematopoietic cancers hepatitis C virus (HCV) hepatocellular carcinoma (HCC) hepatocyte nuclear factor 4 alpha (HNF4A) immune check point immune suppression immunosuppression immunotherapy inflammation inflammation associated cancer inflammatory hepatocellular adenomas interleukin-6 JAK JAK family of protein tyrosine kinases JAK2 V617F knockout lipopolyplex lung cancer lymphocytes lymphoma M2 macrophages melanoma meta-analysis metalloprotease metastasis microRNA-122 (miR-122) mitochondria MPN mTOR multiple myeloma mutations myeloid cells myeloid leukemia n/a nanoparticle neoplastic stem cells NGS NK cells nuclear factor erythroid 2-related factor 2 (NRF2) nuclear pore complex nuclear transport receptors nucleocytoplasmic shuttling ovarian cancer oxidative stress (OS) PD-L1 PEI pharmacological inhibitor pharmacological inhibitors polyethylenimine post-decision state variable prolactin proliferation prostate cancer RHOA risk management S3I-1757 SH2 domain shedding signal transducer and activator of transcription signal transducer and activator of transcription 3 (STAT3) siRNA delivery siRNA/RNAi small-molecule inhibitors solid cancers stabilization STAT STAT transcription factors STAT3 STAT3 inhibitor XIII STAT5 STAT5 signaling STAT5B signaling stem/progenitor cells stemness T-cell large granular lymphocytic leukemia T-cell leukemia T-cell prolymphocytic leukemia T-cells T-PLL targeted therapy targeting therapeutic targeting therapy resistance trans-signaling transaction costs tumor microenvironment tumor necrosis factor alpha (TNFα) tumor suppression tumor-associated macrophages tumor-immune cell interactions tumorigenesis tyrosine kinase 2 unfolded protein response (UPR) |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557623503321 |
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Urological Cancer 2021
| Urological Cancer 2021 |
| Pubbl/distr/stampa | MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 online resource (328 p.) |
| Soggetto topico |
Chemistry
Research & information: general |
| Soggetto non controllato |
177Lu-PSMA
abiraterone ablation margins advanced urothelial carcinoma AHNAK2 autopsy Bacillus Calmette-Guérin (BCG) biomarker biomarkers biopsy bladder cancer bladder cancer cell lines bladder carcinoma cancer cell migration comparative effectiveness comparative oncology ctDNA decision making diagnosis divergent differentiation docetaxel dog enzalutamide epiplakin epithelial-mesenchymal transition fluorescence confocal microscopy focal therapy frail patients frailty FTY-720 game theory genomic analysis genomic signatures glutaminase Hounsfield units image-guided immune checkpoint inhibitor immune checkpoint inhibitors immunohistochemistry immunotherapy in situ methods inflammation inflammatory indices latent cancer liquid biopsy machine learning magnetic resonance imaging mCRPC metastasectomy metastasis metastatic prostate cancer microenvironment molecular subtypes mortality n/a novel hormonal therapies OIP5 oncological outcomes papillary renal cell carcinoma PD-1 PD-L1 PLK1 positron-emission tomography postoperative complications preclinical studies prediction model preneoplastic lesion prognosis prognostic prognostic factor prognostic index prostate prostate biopsy prostate cancer prostatic atrophy prostatic neoplasms PSA PSMA-RLT psoas muscle radical cystectomy radiosensitisation radiotherapy real-world treatment pattern renal cell carcinoma screening trial sphingosine 1-phosphate receptor 1 stereotactic body radiotherapy survival therapy TRIPOD tumor ecology tumor thrombus tumorigenesis tumour mutational board ultrasonography urinary bladder neoplasms urine urothelial carcinoma variant morphology |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910576872803321 |
| MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||